# Prelude Therapeutics Inc: Form SC 13D, filed Oct 5, 2020

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: SC 13D
- Filed: 2020-10-05
- Accepted by EDGAR: Oct 5, 2020, 17:17 ET
- Period: not reported
- Accession: 0000947871-20-000772
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000094787120000772/ss183029_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000094787120000772/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000094787120000772/ss183029_sc13d.htm

Filed Oct 5, 2020.
Source: SEC EDGAR, the filing index for accession 0000947871-20-000772. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
